Next |
home / stock / loxo / loxo message board
Subject | By | Source | When |
---|---|---|---|
If I recall correctly, yes. | Zmill | investorshub | 07/13/2019 12:59:39 PM |
Zmill, did that in-depth research mention anything about | FooBarAndGrill | investorshub | 07/03/2019 9:46:43 PM |
in depth Research on LOXO https://wordpress.com/block-editor/post/msmoneymoves.c | Zmill | investorshub | 07/03/2019 2:36:21 PM |
Cancer drugs - drugs ALONE - $123 BILLION | 0whammies | investorshub | 01/07/2019 2:59:31 PM |
Congrats, LOXO up $91. in PM w/ merger! | crudeoil24 | investorshub | 01/07/2019 12:46:28 PM |
LOXO buy 158.34 | stocktrademan | investorshub | 08/20/2018 12:48:37 AM |
LOXO big move after hours...ASCO presentation | Phoenix300 | investorshub | 05/17/2018 2:05:13 AM |
Summary Employee stock option exercises | FooBarAndGrill | investorshub | 09/30/2017 2:57:36 PM |
The abstract describes the first two patients with | FooBarAndGrill | investorshub | 09/28/2017 3:40:45 PM |
Loxo Oncology, Inc. (Nasdaq:$LOXO), a biopharmaceutical company innovating | FooBarAndGrill | investorshub | 09/28/2017 3:32:53 PM |
Summary of recent 20 Sept. Employee Stock Option | FooBarAndGrill | investorshub | 09/26/2017 3:43:53 PM |
Is it time to buy $LOXO? Up | FooBarAndGrill | investorshub | 09/13/2017 6:11:22 PM |
$LOXO phase 1 results. | FooBarAndGrill | investorshub | 09/13/2017 4:50:22 PM |
Taking this out on a road show. | FooBarAndGrill | investorshub | 09/13/2017 4:42:26 PM |
This is the real deal. | FooBarAndGrill | investorshub | 09/13/2017 4:40:48 PM |
Performing well today in a tough mkt | FooBarAndGrill | investorshub | 06/12/2017 7:16:07 PM |
Genius stock analyst called this one weeks ago, | AugustStockInformer | investorshub | 06/06/2017 8:48:15 PM |
About TRK Fusion Cancer | FooBarAndGrill | investorshub | 06/05/2017 5:30:47 PM |
About $LOXO-195 | FooBarAndGrill | investorshub | 06/05/2017 5:30:09 PM |
A formal $LOXO-195 IND was recently cleared by | FooBarAndGrill | investorshub | 06/05/2017 5:29:24 PM |
News, Short Squeeze, Breakout and More Instantly...
INDIANAPOLIS and STAMFORD, Conn. , Feb. 1, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) ("Lilly") and Loxo Oncology, Inc. (NASDAQ: LOXO) ("Loxo Oncology") today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 197...